Pipeline Embolization for Intracranial Aneurysms

Recruiting Observational Study
Efficacy, Self Hemodynamic Instability Stenosis Aneurysm, Intracranial
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 75
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Zhujiang Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Aged 22 to 75 years old, male or non-pregnant female; 2. UIA was diagnosed by CTA, MRA, or DSA; 3. The size of aneurysms is between 3 to 25mm; 4. Understands the nature of the procedure and provision of written informed consent; 5. Indications for FD implantation with or with…
Contacts

Chuanzhi Duan, MD

020-62782757

doctor_duanzj@163.com

CONTACT

Xin Feng, MD

13681134001

13681134001@163.com

CONTACT